Detail
LncRNA Name | H19 |
Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
Region | GRCh38_11:1995176-2001470 Sequence |
Ensembl | ENSG00000130600 |
RefSeq | NR_002196 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | qPCR, RNAi etc. |
Sample | cell lines (AGS1, MGC803, SGC7901, and MKN46), gastric adenocarcinomas tissues |
Expression Pattern | up-regulated |
Function Description | lncRNAs H19,MEG3 and MALAT1 showed significant association with tumor stage and HOTAIR had a significant association with patient survival.H19 is a well-known oncogenic lncRNA that is involved in the reduction of p53 activity inducing proliferation in gastric cancer.In the present study,we observed a higher level of H19 which sponged out the low level expressed miR-148a leading to the overexpression of its target mRNA DNMT1.Similarly,we also observed the KLF4 overexpression due to the H19 mediated sponging of miR-148a. |
Pubmed ID | 29719612 |
Year | 2018 |
Title | Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer. |
External Links |
Links for H19 | GenBank HGNC lncrnadb Noncode |
Links for gastric cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.